Can a heavy viral infection like glandular fever alter the baseline reading of an HIV p24Ag test?

Introduction

If you have recently had glandular fever — or another significant viral illness — and are wondering whether it could affect the accuracy of an HIV p24Ag test, you are not alone in asking this question. Anxiety around HIV testing can be considerable, and when another infection is present at the same time, it is natural to question whether the result you receive can be trusted. This article aims to address that concern in a calm, clinically grounded way.

Our clinic provides confidential STI testing services. We do not provide GP services or dermatology consultations, but we can advise on appropriate next steps if further medical care is needed.

Quick Answer: Can Glandular Fever Affect an HIV p24Ag Test?

A concurrent viral infection such as glandular fever does not cause the HIV p24 antigen test to produce a false positive for HIV. However, immune system activity during a heavy viral infection may, in some circumstances, create background immunological noise that a laboratory must interpret carefully. Testing during or shortly after acute illness is worth discussing with a clinical adviser.

Key points to be aware of:

• The HIV p24Ag test detects a specific HIV protein, not generalised viral activity
• Glandular fever (Epstein–Barr virus) does not produce the p24 antigen
• A strong immune response may occasionally influence the sensitivity of certain assays
• Borderline or reactive results during acute illness are typically subject to confirmatory testing
• Testing window periods still apply regardless of concurrent illness
• Retesting once recovered may be recommended in some clinical scenarios

Symptoms alone cannot confirm or rule out HIV or any other STI.

When Could a Concurrent Viral Illness Be Linked to Testing Concerns?

If you have recently been unwell with glandular fever and are also concerned about potential HIV exposure, it is understandable to feel uncertain about when and how to test. The two concerns may feel connected because both can cause similar symptoms — including fatigue, swollen lymph nodes, sore throat, and fever. These overlapping presentations do not mean one condition indicates the other. Testing may help provide clarity when there is a genuine potential exposure history.

Section 1: Understanding the HIV p24 Antigen Test

The HIV p24 antigen test is designed to detect a specific protein — the p24 antigen — that forms part of the HIV virus itself. It is one of the earliest detectable markers of HIV infection, typically becoming detectable within 2–4 weeks of exposure. Modern fourth-generation HIV tests combine p24 antigen detection with HIV antibody detection, making them more sensitive than older antibody-only tests in detecting early infection.

The test is highly specific: it targets a protein unique to HIV. It does not react to general viral activity in the body in the same way that some other assays might.

Section 2: What Glandular Fever Actually Does in the Body

Glandular fever, caused by the Epstein–Barr virus (EBV), produces a vigorous immune response. The body generates large quantities of atypical lymphocytes and a range of non-specific antibodies. In some older or less specific assay formats, this kind of broad immune activation has historically been associated with heterophile antibody interference — which is why some older tests could produce unusual results during active EBV infection.

However, modern fourth-generation HIV combination assays used in accredited laboratories are specifically designed and validated to minimise non-specific reactivity. The presence of EBV antibodies or elevated lymphocyte activity does not produce the p24 antigen signal that the test is calibrated to detect.

Section 3: Situations Where Test Interpretation May Be More Complex

There are certain clinical circumstances where the interpretation of any immunological test — including HIV combination assays — may require additional care:

• During acute, severe viral illness — the immune system is highly active, and some non-specific assay reactions are documented in literature, though these are uncommon with modern tests
• Immediately following illness — residual immune activation may persist for a period of weeks
• In individuals with compromised immune function — baseline assay performance may differ
• During seroconversion to a different virus — the production of large volumes of new antibodies may occasionally interact with assay chemistry in borderline cases

In these scenarios, a reactive or borderline result would ordinarily trigger confirmatory testing using a second, independent methodology — which is standard laboratory practice in the UK.

Section 4: STIs That Can Produce Symptoms Similar to Glandular Fever

It is clinically important to note that primary HIV infection itself can present with symptoms similar to glandular fever — including fever, sore throat, swollen glands, and profound fatigue. This presentation is sometimes referred to as a seroconversion illness.

Other STIs worth being aware of in the context of similar symptoms may include:

• Syphilis — secondary syphilis can cause systemic symptoms including rash, lymphadenopathy, and fatigue. A syphilis test can help rule this out.
• Herpes simplex virus (HSV) — primary herpes infection can occasionally cause systemic upset alongside localised symptoms
• Gonorrhoea and chlamydia — typically produce localised rather than systemic symptoms, though disseminated gonorrhoea may cause fever and joint pain in some cases

Symptoms alone cannot confirm the cause. Testing remains the only reliable way to differentiate between conditions.

Section 5: How Overlapping Symptoms Can Create Uncertainty

The challenge with both glandular fever and primary HIV infection is that the symptom profiles are genuinely similar. This is one of the reasons why HIV p24Ag testing was developed — to allow earlier, more reliable detection during the period when clinical symptoms may be present but antibody responses have not yet fully developed.

If symptoms are present and an exposure event has occurred, testing is the most appropriate way to gain clarity rather than attempting to interpret symptoms in isolation.

Section 6: When HIV Testing May Be Sensible

Testing may be a reasonable consideration in the following circumstances:

• A potential exposure event has occurred (unprotected sex, sharing injecting equipment)
• Symptoms consistent with seroconversion illness develop within 2–6 weeks of potential exposure
• A sexual partner has disclosed an HIV diagnosis
• You are starting a new sexual relationship and wish to establish a baseline
• You have not been tested in a significant period of time and have had new sexual partners

Section 7: How HIV Testing Works

A fourth-generation HIV combination test uses a blood sample — typically taken via venepuncture or, in some services, a finger-prick sample — and analyses it in an accredited laboratory. Results detect both the p24 antigen and HIV antibodies (IgG and IgM).

If an initial result is reactive, standard UK laboratory practice dictates that confirmatory testing is performed before any result is communicated as positive. This multi-step process helps protect against the impact of any non-specific reactions, including those that might theoretically arise during concurrent illness.

You may also wish to consider a full STI screen alongside HIV testing if there has been potential exposure to multiple infections.

Section 8: When a Concurrent Illness Is Less Likely to Affect Results

In most clinical cases, glandular fever will not produce a meaningful interference with a modern, fourth-generation HIV p24Ag combination test. Laboratories use validated internal controls and confirmatory pathways specifically to manage the small risk of non-specific reactivity.

If you are in the acute phase of glandular fever and testing for HIV, it is reasonable to inform the clinical team so they can note this on the request and, if appropriate, recommend retesting once you have recovered to provide a cleaner baseline.

Section 9: Frequently Asked Questions

Can glandular fever cause a false positive HIV test?

With modern fourth-generation combination assays, a glandular fever infection is not expected to cause a true false positive HIV result. Any reactive result would be subject to confirmatory testing before conclusions are drawn.

Should I wait until I recover from glandular fever before testing for HIV?

This depends on your circumstances and the urgency of the concern. Discussing your timing with a clinical adviser can help determine the most appropriate approach.

Does the HIV p24Ag test detect other viruses?

No. The p24 antigen test is specific to a protein produced by HIV. It does not react to other viruses including Epstein–Barr virus.

What if my result is borderline or indeterminate?

A borderline result would ordinarily trigger confirmatory testing through a second method. This is standard UK laboratory practice and does not necessarily indicate HIV infection.

How soon after potential exposure can I test for HIV?

A fourth-generation combination test is considered reliable from 45 days post-exposure by some clinical guidelines, though others extend this to 90 days for a definitive negative result. Testing window periods should be interpreted in the context of individual clinical circumstances. Please discuss your specific situation with a clinical adviser.

Are overlapping symptoms between glandular fever and HIV seroconversion common?

Both conditions can cause fatigue, sore throat, lymphadenopathy, and fever. If there has been a potential HIV exposure, testing is the most appropriate way to differentiate the cause.

Section 10: When to Seek Medical Advice

You should consider seeking appropriate medical care if you experience:

• Severe or worsening fatigue not explained by your illness
• Persistent high fever
• Significant or rapidly spreading lymphadenopathy
• Neurological symptoms
• Symptoms that are not improving after the expected course of glandular fever

If symptoms persist or worsen, consultation with an appropriate healthcare service may be advised.

Confidential HIV and STI Testing in the UK

If you are concerned about potential HIV exposure, or wish to discuss the timing of HIV testing in the context of a concurrent viral illness, confidential testing appointments are available at our UK clinic. Testing decisions depend on individual exposure history, symptom presentation, and clinical risk factors. The information provided in this article is not a substitute for a personalised clinical assessment. Treatment and testing suitability should be determined in consultation with a qualified healthcare professional.

You may also wish to explore our dedicated HIV test page for further information on the testing process and window periods.

This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Sexual health concerns should be assessed based on individual circumstances. If you are experiencing persistent, severe, or worsening symptoms, consultation with an appropriate healthcare service is advised. Our clinic provides private STI testing services only.